News Center

Item Category Title Date
21 2018 Outstanding Enterprise Manager Association (OEMA) Award 2018-06-29
22 3D Global Biotech Inc. Bone Substitute Product, Obtained TFDA Medical Device License (No.006017) 2018-01-27
23 Approved as a new biotechnology drug company by the Ministry of Economic Affairs of the Republic of China, and the product developed is "ReCornea Corneal Epithelial Reconstruction Product" 2018-01-23
24 3D Global Biotech Inc. has been approved by GMP (No. GMP1426, Re-absorbed Calcium Salt Bone Cave Filling Device) 2017-11-09
25 Certified by ISO/IEC 17025:2005 Test Laboratory, TAF Number: 3345 2017-07-14
26 2017 Industry Accelerator and Potent Strategy (IAPS) Award, NCTU 2017-01-12
27 Subsidy from the Small Business Innovation Research(SBIR) Project of the Ministry of Economy Affairs, Project No.1Z1050620 2016-10-21